This session addresses the complexities of lymphadenectomy in salvage esophagectomy for recurrent or persistent esophageal cancer. Dr. T.S. Rao discusses the technical and clinical challenges associated with prior treatments such as chemoradiotherapy, highlighting the importance of specialized, high-volume centers. Key topics include complication management, preservation of critical structures such as bronchial arteries, and operative strategies in high-risk settings.

The session concludes with an expert Q&A moderated by Dr. Caleb Harris, covering extent of dissection, recurrent laryngeal nerve management, thoracic duct preservation, and the use of imaging such as FDG PET-CT in guiding lymphadenectomy.


You may also like

Treatment of T1 Cancer Associated with Barrett's Esophagus - Endoscopic Resection Should Be Done – Michael Bourke
•
2views•
0likes
Listen to Dr. Michael Bourke present during the Esophageal Debates Session, held during the 2025 ISDE World Congress in Brisbane, Australia, from September 18-20, 2025. Watch all presentations in this session, including: Treatment of T1 Cancer ...
ISDE Members Only
Esophageal Cancer: Screening and Endoscopic Therapies - Anthony Gamboa
•
13views•
0likes
Anthony Gamboa of Vanderbilt University Medical Center (United States) presented on early detection and intervention strategies for esophageal cancer, focusing on Barrett's esophagus as a precancerous condition. He discussed screening methods ...
Researching The Use Biomarkers for Managing Barrett’s Esophagus
•
34views•
0likes
Watch Dr. David Lui interview Professor Sheila K. Krishnadath discuss the recent approval of a research project focusing on biomarkers. The grant is the culmination of many years of research looking at biomarkers as a means of making clinical ...
Long Term PPI Therapy: Controversies in GERD Part 1 with Kerry Dunbar
•
15views•
0likes
Gastroesophageal Reflux Disease (GERD) is the most prevalent esophageal disease. It is a condition affecting up to 20% of the western world and has a significant negative impact in the patient’s quality of life. The typical symptoms are ...
Post-operative Outcomes after Chemoradiation versus Chemotherapy: Surgical Results from the ESOPEC Trial – Olga Meier
•
1views•
0likes
Listen to Dr. Olga Meier present during the second Presidential Plenary Session comprising 2 state-of-the-art lectures by leaders in their respective fields (benign and malignant) followed by the top 2 submitted abstracts in each field. This ...
ISDE Members Only
Exploring Communication and Collaboration in our International, Multidisciplinary Esophageal Community – Walter Chan
•
1views•
0likes
Digital and social media play a crucial role in communication within the esophageal community, fostering collaboration among professionals and patients. With nearly 70% of the global population using social media, it serves as a vital tool for ...
ISDE Members Only
Multidisciplinary Conference of Benign Esophageal Disease: Case 3
•
4views•
0likes
Listen to the panel discussion on Case 3 of 5 of the Multidisciplinary Tumour Board, moderated by Mark Smithers and Nicholas Shaheen. The international panel of experts included: Gastroenterology panelists: Peter Kahrilas, Sachin Wani, Vani ...
ISDE Members Only
Giant Paraoesophageal Hernia - When is Resection Justified and What Are the Options? – Sheraz Markar
•
3views•
0likes
Listen to Dr. Sheraz Markar present during the Giant Hiatus Hernia Session, held during the 2025 ISDE World Congress in Brisbane, Australia, from September 18-20, 2025. Watch all presentations in this session, including: Fundoplication after ...
ISDE Members Only
Oesophageal Cancer Surgery in Australia: Where It Has Come from and Where It Is Heading – Mark Smithers
•
0views•
0likes
Listen to Dr. Mark Smithers present during the AANZGOSA-ISDE Joint Session on Challenges and Dilemmas from the Experts, held during the 2025 ISDE World Congress in Brisbane, Australia, from September 18-20, 2025. Watch all presentations in this ...
ISDE Members Only
Page 15 of 17